Table 2.
Outcome | Time point |
---|---|
Time to first respiratory exacerbation | |
Time to death | |
Number of acute exacerbations | By 12 months |
Number of hospitalisations | By 12 months |
Number of mild, moderate and severe adverse events | By 12 months |
Mean weight-for-age z-score adjusted for baseline | By 12 months |
Incidence of infectious episodes (Salmonella typhi, malaria, gastroenteritis) | By 12 months |
Durability of effect (FEV1 z-score) | 18 months |
FEV 1 Forced expiratory volume in 1 second